Antimicrobial resistance 1979-2009 at Karolinska hospital, Sweden: Normalized resistance interpretation during a 30-year follow-up on Staphylococcus aureus and Escherichia coli resistance development

APMIS

Volumn 118, Issue 9, 2010, Pages 621-639

  Kronvall, Göran ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antimicrobial resistance; disc diffusion test; epidemiological breakpoints; NRI; resistance surveillance

Indexed keywords

AMPICILLIN; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; NITROFURANTOIN; NORFLOXACIN; PIPERACILLIN; RIFAMPICIN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; ESCHERICHIA COLI; FOLLOW UP; NONHUMAN; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; SWEDEN;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SWEDEN;

EID: 77955939817     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02660.x     Document Type: Review

References (98)

1. Rammelkamp CH, Maxon T. Resistance of Staphylococcus aureus to the action of penicillin. Proc Soc Exp Biol Med 1942 31 : 386 9.
2. Finland M, Jones WF, Barnes MW. Occurrence of serious bacterial infections since introduction of antibacterial agents. JAMA 1959 170 : 2188 97.
3. CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard - Sixth Edition, M7-A6.
4. EUCAST. Determination of minimum inhibitory concentration (MIC) by agar dilution. EUCAST Discussion Document. European Society of Clinical Microbiology and Infectious Diseases (ESCMID), European Committee for Antimicrobial Susceptibility Testing (EUCAST). Clin Microbiol Infect 2000 6 : 1 7.
5. Wheat PF, Spencer RC. The evolution of in-vitro antimicrobial susceptibility techniques. J Antimicrob Chemother 1988 22 : 579 82.
6. Ericsson H, Högman C, Wickman K. A paper disk method for determination of bacterial sensitivity to chemotherapeutic and antibiotic agents. Scand J Clin Lab Invest 1954 6 : 23 36.
7. Ericsson HM, Sherris JC. Antibiotic sensitivity testing. Report of an International Collaborative Study. Acta Pathol Microbiol Scand Sect B 1971 217 (Suppl 1 90.
8. Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966 45 : 493 6.
9. Jones RN. Recent trends in the College of American Pathologists Proficiency Results for Antimicrobial Susceptibility Testing: Preparing for CLIA '88. Clin Microbiol Newslett 1992 14 : 33 7.
10. Petersdorf RG, Plorde JJ. The usefulness of in vitro sensitivity tests in antibiotic therapy. Annu Rev Med 1963 14 : 41 56.
11. Stokes EJ. Antibacterial drugs. Clin Bacteriol 1955 157 92.
12. FDA. Antibiotic susceptibility discs. Fed Regist 1972 37 : 20525 9.
13. FDA. Antibiotic susceptibility discs - corrections. Fed Regist 1973 38 : 2576.
14. CLSI. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard - Eighth Edition, M2-A8.
15. Andrews JM. BSAC standardized disc susceptibility testing method. J Antimicrob Chemother 2001 48 (Suppl 1 43 57.
16. Andrews JM. BSAC standardized disc susceptibility testing method (version 8). J Antimicrob Chemother 2009 64 : 454 89.
17. Brown D, MacGowan A. Harmonization of antimicrobial susceptibility testing breakpoints in Europe: implications for reporting intermediate susceptibility. J Antimicrob Chemother 2010 65 : 183 5.
18. O'Brien TF, Norton RA, Kent RL, Medeiros AA. International surveillance of prevalence of antibiotic resistance. J Antimicrob Chemother 1977 3 : 59 66.
19. O'Brien TF, Mayer KH, Hopkins JD. Global Surveillance of the Deployment of Antibiotic Resistance Genes and Plasmids. Antibiotic Resistance Genes: Ecology, Transfer, and Expression. Banbury Report 24, Cold Spring Harbor Laboratory, 1986 : 3 15.
20. Vandepitte J, El-Nageh MM, Tikhomirov E, Stelling JM, Estrela A. Guidelines for antimicrobial resistance surveillance. In : El-Nageh MM, editor. Alexandria, Egypt, World Health Organization, Regional Office for the Eastern Mediterranean.
21. Sahm DF, Tenover FC. Surveillance for the emergence and dissemination of antimicrobial resistance in bacteria [Review] [43 refs]. Infect Dis Clin North Am 1997 11 : 767 83.
22. Putnam SD, Riddle MS, Wierzba TF, Pittner BT, Elyazeed RA, El-Gendy A, et al. Antimicrobial susceptibility trends among Escherichia coli and Shigella spp. isolated from rural Egyptian paediatric populations with diarrhoea between 1995 and 2000. Clin Microbiol Infect 2004 10 : 804 10.
23. Jones RN. Detection of emerging resistance patterns within longitudinal surveillance systems: data sensitivity and microbial susceptibility. J Antimicrob Chemother 2000 46 : 1 8.
24. Masterton RG. Surveillance studies: how can they help the management of infection? J Antimicrob Chemother 2000 46 : 53 8.
25. Bax R, Bywater R, Cornaglia G, Goossens H, Hunter P, Isham V, et al. Surveillance of antimicrobial resistance - what, how and whither? Clin Microbiol Infect 2001 7 : 316 25.
26. O'Brien TF. Improve and Expand Surveillance. Antibiotic Resistance: Synthesis of Recommendations by Expert Policy Groups.
27. WHO. Surveillance Standards for Antimicrobial Resistance.
28. Kahlmeter G, Brown DF. Resistance surveillance studies - comparability of results and quality assurance of methods. J Antimicrob Chemother 2002 50 : 775 7.
29. Cornaglia G, Hryniewicz W, Jarlier V, Kahlmeter G, Mittermayer H, Stratchounski L, et al. European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect 2004 10 : 349 83.
30. Hayward AC, Goldsmith K, Johnson AM, on behalf of the Surveillance Subgroup of SACAR. Report of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR) Surveillance Subgroup. J Antimicrob Chemother 2007 60 : i33 42.
31. Livermore DM, Pearson A. Antibiotic resistance: location, location, location. Clin Microbiol Infect 2007 13 : 7 16.
32. Masterton R. The importance and future of antimicrobial surveillance studies. Clin Infect Dis 2008 47 (Suppl 1 S21 31.
33. Reynolds R, Lambert PC, Burton PR, on behalf of the BSAC Extended Working Parties on Resistance Surveillance. Analysis, power and design of antimicrobial resistance surveillance studies, taking account of inter-centre variation and turnover. J Antimicrob Chemother 2008 62 : ii29 39.
34. Reynolds R, Hope R, Williams L. Survey, laboratory and statistical methods for the BSAC Resistance Surveillance Programmes. J Antimicrob Chemother 2008 62 (Suppl 2 ii15 28.
35. Rempel OR, Laupland KB. Surveillance for antimicrobial resistant organisms: potential sources and magnitude of bias. Epidemiol Infect 2009 137 : 1665 73.
36. Kahlmeter G, Brown DF, Goldstein FW, MacGowan AP, Mouton JW, Österlund A, et al. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J Antimicrob Chemother 2003 52 : 145 8.
37. Darveau M, Ducharme-Desilets C, Archambault P, Marcoux D. Translating evidence into practice: the importance of continuing local bacterial surveillance even when national data are available. Infect Control Hosp Epidemiol 2009 30 : 1128 30.
38. Moellering RC Jr., Kunz LJ. Determination of susceptibility of 24,108 gram-negative bacteria to tobramycin and other antibiotics utilizing a computerized system with electronic zone analyzer. Tobramycin: Selected Proceedings from the Eighth International Congress of Chemotherapy, Athens, September 8-15, 1973 1974 : 72 8. Athens, Excerpta Medica.
39. Wagenlehner FM, Niemetz AH, Weidner W, Naber KG. Spectrum and antibiotic resistance of uropathogens from hospitalised patients with urinary tract infections: 1994-2005. Int J Antimicrob Agents 2008 31 (Suppl 1 S25 34.
40. Abelson Storby K, Österlund A, Kahlmeter G. Antimicrobial resistance in Escherichia coli in urine samples from children and adults: a 12 year analysis. Acta Paediatr 2004 93 : 487 91.
41. De Backer D, Christiaens T, Heytens S, De Sutter A, Stobberingh EE, Verschraegen G. Evolution of bacterial susceptibility pattern of Escherichia coli in uncomplicated urinary tract infections in a country with high antibiotic consumption: a comparison of two surveys with a 10 year interval. J Antimicrob Chemother 2008 62 : 364 8.
42. Bean DC, Krahe D, Wareham DW. Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006. Ann Clin Microbiol Antimicrob 2008 7 : 13.
43. Sörberg M, Farra A, Ransjö U, Grdlund B, Rylander M, Wallén L, et al. Long-term antibiotic resistance surveillance of gram-negative pathogens suggests that temporal trends can be used as a resistance warning system. Scand J Infect Dis 2002 34 : 372 8.
44. Ringertz S, Bellete B, Karlsson I, Öhman G, Gedebou M, Kronvall G. Antibiotic susceptbility of Escherichia coli isolates from patients with urinary tract infections in hospitals in Addis Ababa and Stockholm. Bull WHO 1990 68 : 61 8.
45. Phillips I, King A, Gransden WR, Eykyn SJ. The antibiotic sensitivity of bacteria isolated from the blood of patients in St Thomas' Hospital, 1969-1988. J Antimicrob Chemother 1990 25 (Suppl C 59 80.
46. O'Brien TF, Acar JF, Medeiros AA, Norton RA, Goldstein F, Kent RL. International comparison of prevalence of resistance to antibiotics. JAMA 1978 239 : 1518 23.
47. Atkinson BA, Lorian V. Antimicrobial agent susceptibility patterns of bacteria in hospitals from 1971 to 1982. J Clin Microbiol 1984 20 : 791 6.
48. Felmingham D, Washington J. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens - findings of the Alexander Project 1992-1996. J Chemother 1999 11 (Suppl 1 5 21.
49. Jacobs MR, Felmingham D, Appelbaum PC, Gruneberg RN, the Alexander Project Group. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003 52 : 229 46.
50. Felmingham D, White AR, Jacobs MR, Appelbaum PC, Poupard J, Miller LA, et al. The Alexander Project: the benefits from a decade of surveillance. J Antimicrob Chemother 2005 56 : ii3 21.
51. Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD. Antimicrobial susceptibility of gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Int J Antimicrob Agents 2007 30 : 143 9.
52. Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2007 58 : 163 70.
53. Bell J, Turnidge J. SENTRY Antimicrobial Surveillance Program Asia-Pacific region and South Africa. Commun Dis Intell 2003 27 (Suppl S61 6.
54. Jones RN. Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997-2001). Semin Respir Crit Care Med 2003 24 : 121 34.
55. Castanheira M, Sader HS, Deshpande LM, Fritsche TR, Jones RN. Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo - lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 2008 52 : 570 3.
56. Fedler KA, Biedenbach DJ, Jones RN. Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents. Diagn Microbiol Infect Dis 2006 56 : 427 36.
57. Turner PJ. MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): a global overview. J Antimicrob Chemother 2000 46 : 9 23.
58. Jones RN, Mendes C, Turner PJ, Masterton R. An overview of the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) program: 1997-2004. Diagn Microbiol Infect Dis 2005 53 : 247 56.
59. Stelling JM, Travers K, Jones RN, Turner PJ, O'Brien TF, Levy SB. Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs. Emerg Infect Dis 2005 11 : 873 82.
60. Dornbusch K, Miller GH, Hare RS, Shaw KJ. Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood report from a European collaborative study. The ESGAR Study Group (European Study Group on Antibiotic Resistance). J Antimicrob Chemother 1990 26 : 131 44.
61. Dornbusch K. Resistance to beta-lactam antibiotics and ciprofloxacin in gram-negative bacilli and staphylococci isolated from blood: a European collaborative study. J Antimicrob Chemother 1990 26 : 269 78.
62. Dornbusch K, King A, Legakis N, European Study Group on Antibiotic Resistance. Incidence of antibiotic resistance in blood and urine isolates from hospitalized patients. Report from a European Collaborative Study Group on Antibiotic Resistance (ESGAR). Scand J Infect Dis 1998 30 : 281 8.
63. Livermore DM, Threlfall EJ, Reacher MH, Johnson AP, James D, Cheasty T, et al. Are routine sensitivity test data suitable for the surveillance of resistance? Resistance rates amongst Escherichia coli from blood and CSF from 1991-1997, as assessed by routine and centralized testing. J Antimicrob Chemother 2000 45 : 205 11.
64. Tillotson GS, Draghi DC, Sahm DF, Tomfohrde KM, del Fabro T, Critchley IA. Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study. J Antimicrob Chemother 2008 62 : 109 15.
65. Styers D, Sheehan DJ, Hogan P, Sahm DF. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 2006 5 : 2.
66. Turnidge J, McCarthy LR, Master RN, Kepner DE, Weslock J. TSN Database Australia, a new tool to monitor antimicrobial resistance in Australia. Commun Dis Intell 2003 27 (Suppl S67 9.
67. Karlowsky JA, Jones ME, Draghi DC, Thornsberry C, Sahm DF, Volturo GA. Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Ann Clin Microbiol Antimicrob 2004 3 : 7.
68. Turnidge J, McCarthy LR, Master RN, Kepner DE. Low levels of fluoroquinolone resistance in Escherichia coli. A five-year trend in Australia measured through the use of TSN Database Australia. Commun Dis Intell 2003 27 (Suppl S89 91.
69. Jones ME, Draghi DC, Thornsberry C, Karlowsky JA, Sahm DF, Wenzel RP. Emerging resistance among bacterial pathogens in the intensive care unit - a European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob 2004 3 : 14.
70. Jones ME, Karlowsky JA, Draghi DC, Thornsberry C, Sahm DF, Bradley JS. Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine, and skin and soft tissue infections in pediatric patients. Eur J Clin Microbiol Infect Dis 2004 23 : 445 55.
71. Kronvall G, Kahlmeter G, Myhre E, Galas MF. A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes. Clin Microbiol Infect 2003 9 : 120 32.
72. Kronvall G. Determination of the real standard distribution of susceptible strains in zone histograms. Int J Antimicrob Agents 2003 22 : 7 13.
73. Joneberg J, Rylander M, Galas MF, Carlos C, Kronvall G. Analysis of parameters and validation of method for normalized interpretation of antimicrobial resistance. Int J Antimicrob Agents 2003 21 : 525 35.
74. Kronvall G, Ringertz S, Nyström S, Rylander M, Theodorsson E. Comparison of 30 g and 120 g gentamicin disks for the prediction of gentamicin resistance in Enterococcus faecalis. APMIS 1991 99 : 887 92.
75. Kronvall G, Hagelberg A. Numerical evaluation of minimal biochemical test combinations for the identification of Enterobacteriaceae species. APMIS 2002 110 : 451 7.
76. Cowan ST, Steel KJ. Cowan and Steel's Manual for the Identification of Medical Bacteria, 2nd edition.
77. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. Manual of Clinical Microbiology.
78. Olsson-Liljequist B, Larsson P, Walder M, Miörner H. Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing. Scand J Infect Dis 1997 Suppl 105 : 13 23.
79. Bauer AW, Perry DM, Kirby WM. Single-disk antibiotic-sensitivity testing of staphylococci; an analysis of technique and results. AMA Arch Intern Med 1959 104 : 208 16.
80. Alestig K, Bertler, Brorson JE, Burman LG, Dornbusch K, Ericson C, et al. A revised system for antibiotic sensitivity testing. The Swedish Reference Group for antibiotics. Scand J Infect Dis 1981 13 : 148 52.
81. Kronvall G, Runehagen A. Förbättrad känslighetsbedö mning av bakterier medelst artrelaterat SIR-system (Improved determination of antibiotic susceptibility of bacteria using species-related SIR interpretation). Läkartidningen 1981 78 : 3483 5.
82. Kronvall G, Ringertz S. Antibiotic disk diffusion testing revisited. Single strain regression analysis. Review article. APMIS 1991 99 : 295 306.
83. Kronvall G, Ringertz S, Karlsson I, Göransson E, Dornbusch K. Laboratory- and species-specific interpretive breakpoints for disk diffusion tests of chloramphenicol susceptibility of Haemophilus influenzae. Antimicrob Agents Chemother 1988 32 : 1484 9.
84. Ringertz S, Olsson-Liljequist B, Kahlmeter G, Kronvall G. Antimicrobial susceptibility testing in Sweden. II. Species-related zone diameter breakpoints to avoid interpretive errors and guard against unrecognized evolution of resistance. Scand J Infect Dis 1997 Suppl 105 : 8 12.
85. Kronvall G, Karlsson I, Walder M, Sörberg M, Nilsson LE. Epidemiological MIC cut-off values for tigecycline calculated from Etest MIC values using normalized resistance interpretation. J Antimicrob Chemother 2006 57 : 498 505.
86. de Kraker M, van de Sande-Bruinsma N. Trends in antimicrobial resistance in Europe: update of EARSS results. Euro Surveill 2007 12 : pii=3156.
87. Nys S, Terporten PH, Hoogkamp-Korstanje JAA, Stobberingh EE, on behalf of the Susceptibility Surveillance Study Group. Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in the Netherlands (1998-2005). J Antimicrob Chemother 2008 62 : 126 32.
88. Ransjö U, Malm M, Hambraeus A, Artursson G, Hedlund A. Methicillin-resistant Staphylococcus aureus in two burn units: clinical significance and epidemiological control. J Hosp Infect 1989 13 : 355 65.
89. Farra A, Skoog G, Wallén L, Kahlmeter G, Kronvall G, Sörberg M, et al. Antibiotic use and Escherichia coli resistance trends for quinolones and cotrimoxazole in Sweden. Scand J Infect Dis 2002 34 : 449 55.
90. Mick V, Dominguez MA, Tubau F, Linares J, Pujol M, Martin R. Molecular characterization of resistance to rifampicin in an emerging hospital-associated methicillin-resistant Staphylococcus aureus clone ST228, Spain. BMC Microbiol 2010 10 : 68.
91. Sekiguchi J, Fujino T, Araake M, Toyota E, Kudo K, Saruta K, et al. Emergence of rifampicin resistance in methicillin-resistant Staphylococcus aureus in tuberculosis wards. J Infect Chemother 2006 12 : 47 50.
92. Wichelhaus TA, Boddinghaus B, Besier S, Schafer V, Brade V, Ludwig A. Biological cost of rifampin resistance from the perspective of Staphylococcus aureus. Antimicrob Agents Chemother 2002 46 : 3381 5.
93. Giske CG, Borén C, Wretlind B, Kronvall G. Meropenem susceptibility breakpoint for Pseudomonas aeruginosa strains hyperproducing mexB mRNA. Clin Microbiol Infect 2005 11 : 662 9.
94. Sundqvist M, Geli P, Andersson DI, Sjölund-Karlsson M, Runehagen A, Cars H, et al. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J Antimicrob Chemother 2010 65 : 350 60.
95. Smith P, Ruane NM, Douglas I, Carroll C, Kronvall G, Fleming GTA. Impact of inter-lab variation on the estimation of epidemiological cut-off values for disc diffusion susceptibility test data for Aeromonas salmonicida. Aquaculture 2007 272 : 168 79.
96. Ruane NM, Douglas I, Geary M, Carroll C, Fleming GTA, Smith P. Application of normalised resistance interpretation to disc diffusion data on the susceptibility of Aeromonas salmonicida to three quinolone agents. Aquaculture 2007 272 : 156 67.
97. Smith P, Christofilogiannis P. Application of normalised resistance interpretation to the detection of multiple low-level resistance in strains of Vibrio anguillarum obtained from Greek fish farms. Aquaculture 2007 272 : 223 30.
98. Smith P, Douglas I, McMurray J, Carroll C. A rapid method of improving the criteria being used to interpret disc diffusion antimicrobial susceptibility test data for bacteria associated with fish diseases. Aquaculture 2009 290 : 172 8.